Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 3,252 shares at $32.75 ($107K) on 2023-11-22, disclosed to the SEC on 2023-11-24.
Open-market sale of $107k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.75 | 3,128 | $102K | 96.1% |
| 2 | $33.52 | 124 | $4K | 3.9% |
| Total | $32.78 avg | 3,252 | $107K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |